0001127602-23-007927.txt : 20230301 0001127602-23-007927.hdr.sgml : 20230301 20230301165302 ACCESSION NUMBER: 0001127602-23-007927 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230228 FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAIN ALAN J CENTRAL INDEX KEY: 0001227372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30111 FILM NUMBER: 23694520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE DATE OF NAME CHANGE: 20070426 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2023-02-28 0001062822 LEXICON PHARMACEUTICALS, INC. LXRX 0001227372 MAIN ALAN J 2445 TECHNOLOGY FOREST BLVD. 11TH FLOOR THE WOODLANDS TX 77381 1 EVP, Innov & Chem Sciences Common Stock 2023-02-28 4 M 0 23300 A 198889 D Common Stock 2023-02-28 4 M 0 8976 A 207865 D Common Stock 2023-02-28 4 M 0 25667 A 233532 D Common Stock 2023-02-28 4 F 0 20946 2.17 D 212586 D Restricted Stock Units 2023-02-28 4 M 0 23300 D Common Stock 23300 0 D Restricted Stock Units 2023-02-28 4 M 0 8976 D Common Stock 8976 8977 D Restricted Stock Units 2023-02-28 4 M 0 25667 D Common Stock 25667 51333 D Each restricted stock unit represents a contingent right to receive one share of common stock. Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. /s/ Alan J. Main, Ph.D. 2023-03-01